Company Filing History:

6 out of 377

Aventis Pharma S.a.

Years Active: 2002-2012

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8148540 - Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents (2012-04-03),

2. 7439253 - Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors (2008-10-21),

3. 7288549 - Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents (2007-10-30),

4. 6812331 - Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments (2004-11-02),

5. 6583119 - Aromatic amides, preparation method and application as medicines (2003-06-24),

6. 6579902 - Ribose-substituted aromatic amides, method for the production and use thereof as medicaments (2003-06-17),

7. 6420538 - Aromatic amides, preparation method and application as medicines (2002-07-16),

8. 6350733 - Aromatic derivatives substituted by a ribose, their method of preparation and application as medicine (2002-02-26),

Title: Innovations in Medicine: The Contributions of Branislav Musicki

Introduction

Branislav Musicki, an inventive mind based in Paris, France, has made significant strides in the field of medicinal chemistry. With a total of eight patents to his name, he has contributed to the development of innovative compounds, particularly in the area of anti-bacterial agents.

Latest Patents

Musicki's latest patents showcase his commitment to advancing medical treatments. One of his notable inventions includes the creation of heterocyclic compounds, their preparation and their use as medicaments, specifically as anti-bacterial agents. This invention involves a novel general formula (I) and details a process for preparing these compounds. Furthermore, he has developed another series of heterocyclic compounds, focusing on their use as antibacterials and beta-lactamase inhibitors. These compounds are designed to combat bacterial resistance, posing a significant challenge in modern medicine.

Career Highlights

Throughout his career, Branislav Musicki has been associated with prestigious pharmaceutical companies, including Aventis Pharma S.A. and Novexel. His experience in these institutions reflects his dedication to research and innovation, where he has played a crucial role in developing new medicaments that have the potential to improve patient outcomes.

Collaborations

In the course of his career, Musicki has collaborated with notable professionals such as Michel Klich and Patrick Laurin. These partnerships have enabled him to enhance his research and drive forward innovative solutions in the pharmaceutical industry.

Conclusion

Branislav Musicki’s contributions to medicinal chemistry through his patented innovations highlight the importance of ongoing research and development in combating bacterial infections. His work not only demonstrates a commitment to scientific advancement but also reflects the collaborative spirit essential for breakthroughs in healthcare. With a robust foundation of patents and collaborations, Musicki continues to stand at the forefront of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com